NAMSA offers only the most proven strategies & solutions that help translate Great Ideas into Great Medical Products
Product Development Strategy
From concept to post-market, NAMSA’s Product Development Strategy (PDS) service offering provides proven solutions to assist clients with any development challenge, therapeutic area, reimbursement issue or regulatory environment.
Medical Device Testing
NAMSA is the pioneer of the medical device testing industry and continues to serve as the global marketplace leader for reliable, proven testing services.
Biological Safety Consulting
NAMSA offers a range of biological safety solutions to ensure your medical device development program is compliant, while also focusing on the most efficient means possible to complete necessary tests.
The global medical device landscape is complex. Getting a new product or therapy approved requires compelling clinical evidence. At NAMSA, we know what you’re up against and understand how to set you up for success.
NAMSA offers a full range of preclinical research solutions for imaging, data collection, pathology and histopathology.
Regulatory and Quality Consulting
NAMSA is the industry leader in driving successful regulatory submissions and outcomes through effective, daily interactions with the U.S. FDA, Japan’s PMDA, Europe’s EMA, and China’s NMPA, as well as other international Notified Bodies.
NAMSA is the industry leader in driving successful device approval and commercialization outcomes through world-class medical writing services.
NAMSA offers a full continuum of reimbursement services and solutions for new and existing medical technologies. Our teams are expert in all aspects of reimbursement strategy, including: payer relations, medical policy research, coverage advocacy, HCPCS and CPT code analysis/applications and health economic analysis.
NAMSA’s stand-alone IVD business unit, the only within the Contract Research Organization (CRO) industry, is focused on meeting the unique product development needs of IVD manufacturers.